Citadel Advisors’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.07M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $103K | Sell |
|
|||||
|
2024
Q3 | $194K | Sell |
|
|||||
|
2024
Q2 | $1.73M | Buy |
|
|||||
|
2024
Q1 | $2.73M | Buy |
|
|||||
|
2023
Q4 | $267K | Sell |
|
|||||
|
2023
Q3 | $733K | Sell |
|
|||||
|
2023
Q2 | $1.84M | Buy |
|
|||||
|
2023
Q1 | $1.66M | Buy |
|
|||||
|
2022
Q4 | $2.24M | Buy |
|
|||||
|
2022
Q3 | $1.14M | Buy |
|
|||||
|
2022
Q2 | $211K | Sell |
|
|||||
|
2022
Q1 | $2.63M | Sell |
|
|||||
|
2021
Q4 | $5.21M | Buy |
|
|||||
|
2021
Q3 | $1.8M | Sell |
|
|||||
|
2021
Q2 | $4.19M | Buy |
|
|||||
|
2021
Q1 | $749K | Sell |
|
|||||
|
2020
Q4 | $3.44M | Buy |
|